SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee, Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection, Clinical and Molecular Hepatology, 2016, 22, 3, 366

    CrossRef

  2. 2
    Jong Man Kim, Outcomes for Patients with Hepatitis C Virus after Liver Transplantation in Korea, The Journal of the Korean Society for Transplantation, 2016, 30, 4, 155

    CrossRef

  3. 3
    Gorden Muduma, Rhodri Saunders, Isaac Odeyemi, Richard F. Pollock, Helge Bruns, Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant, PLOS ONE, 2016, 11, 11, e0160421

    CrossRef

  4. 4
    Marina Berenguer, John R. Lake, Transplantation of the Liver, 2015,

    CrossRef

  5. 5
    J. Howell, P. Angus, P. Gow, Hepatitis C recurrence: the Achilles heel of liver transplantation, Transplant Infectious Disease, 2014, 16, 1
  6. 6
    G. Levy, F. G. Villamil, F. Nevens, H. J. Metselaar, P.-A. Clavien, G. Klintmalm, R. Jones, M. Migliaccio, H. Prestele, R. Orsenigo, REFINE: A Randomized Trial Comparing Cyclosporine A and Tacrolimus on Fibrosis After Liver Transplantation for Hepatitis C, American Journal of Transplantation, 2014, 14, 3
  7. 7
    Zhenmin Liu, Yi Chen, Renchuan Tao, Jing Xv, Jianyuan Meng, Xiangzhi Yong, Rafael Aldabe, Tacrolimus-Based versus Cyclosporine-Based Immunosuppression in Hepatitis C Virus-Infected Patients after Liver Transplantation: A Meta-Analysis and Systematic Review, PLoS ONE, 2014, 9, 9, e107057

    CrossRef

  8. 8
    Stephen Frausto, Emily Lee, Hengli Tang, Cyclophilins as Modulators of Viral Replication, Viruses, 2013, 5, 7, 1684

    CrossRef

  9. 9
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Living-Donor Liver Transplantation and Hepatitis C, HPB Surgery, 2013, 2013, 1

    CrossRef

  10. 10
    R. C. Gehrau, V. R. Mas, F. G. Villamil, C. I. Dumur, N. K. Mehta, J. L. Suh, D. G. Maluf, MicroRNA Signature at the Time of Clinical HCV Recurrence Associates With Aggressive Fibrosis Progression Post-Liver Transplantation, American Journal of Transplantation, 2013, 13, 3
  11. 11
    Christophe Duvoux, Roberto Firpi, Gian L. Grazi, Gary Levy, Eberhard Renner, Federico Villamil, Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor, Transplant International, 2013, 26, 4
  12. 12
    YoungRok Choi, Kwang-Woong Lee, The Management of HCV Recurrence after Liver Transplantation, The Journal of the Korean Society for Transplantation, 2013, 27, 2, 37

    CrossRef

  13. 13
    Angel Rubín, Marina Berenguer, Trasplante hepático: inmunosupresión personalizada en pacientes con hepatitis C y carcinoma hepatocelular, Gastroenterología y Hepatología, 2013, 36, 1, 48

    CrossRef

  14. 14
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplantation, American Journal of Transplantation, 2013, 13, s4
  15. 15
    Harald Farnik, Christoph Sarrazin, Behandlung von Lebertransplantationspatienten mit chronischer Virushepatitis, Viszeralmedizin, 2012, 28, 5, 304

    CrossRef

  16. 16
    Ali Zarrinpar, Ronald W Busuttil, Immunomodulating options for liver transplant patients, Expert Review of Clinical Immunology, 2012, 8, 6, 565

    CrossRef

  17. 17
    Dimitrios N. Samonakis, Giacomo Germani, Andrew K. Burroughs, Immunosuppression and HCV recurrence after liver transplantation, Journal of Hepatology, 2012, 56, 4, 973

    CrossRef

  18. 18
    Aaron James Chan, John R. Lake, Immunosuppression in HCV-positive liver-transplant recipients, Current Opinion in Organ Transplantation, 2012, 17, 6, 648

    CrossRef

  19. 19
    Robin D. Kim, Shugo Mizuno, John B. Sorensen, Jason J. Schwartz, Shiro Fujita, Impact of Calcineurin Inhibitors on Hepatitis C Recurrence After Liver Transplantation, Digestive Diseases and Sciences, 2012, 57, 2, 568

    CrossRef

  20. 20
    Norman M. Kneteman, Sonal Asthana, Jamie Lewis, Chelcey Dibben, Donna Douglas, Mahra Nourbakhsh, Lorne J. Tyrrell, Garry Lund, Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection, Liver Transplantation, 2012, 18, 1
  21. 21
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  22. 22
    Manav Wadhawan, Sunil Taneja, Rajeev Shandil, Neerav Goyal, Subash Gupta, Ajay Kumar, Management of chronic hepatitis C before and after liver transplant, Apollo Medicine, 2012, 9, 1, 24

    CrossRef

  23. 23
    Ellen Hulskotte, Samir Gupta, Fengjuan Xuan, Marga van Zutven, Edward O'Mara, Hwa-Ping Feng, John Wagner, Joan Butterton, Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers, Hepatology, 2012, 56, 5
  24. 24
    Marina Berenguer, Ramón Charco, Juan Manuel Pascasio, Jose Ignacio Herrero, Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation, Liver International, 2012, 32, 5
  25. 25
    Shigeru Marubashi, Koji Umeshita, Toshimasa Asahara, Kenji Fujiwara, Hironori Haga, Takashi Hashimoto, Katsuyoshi Hatakeyama, Takafumi Ichida, Takashi Kanematsu, Masaki Kitajima, Kendo Kiyosawa, Masatoshi Makuuchi, Shinichi Miyagawa, Susumu Satomi, Yuji Soejima, Yasutsugu Takada, Noriaki Tanaka, Satoshi Teraoka, Morito Monden, Steroid-free living donor liver transplantation for HCV – a multicenter prospective cohort study in Japan, Clinical Transplantation, 2012, 26, 6
  26. 26
    Mauricio Garcia-Saenz-de-Sicilia, Sandeep Mukherjee, The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice, Expert Review of Clinical Pharmacology, 2012, 5, 5, 587

    CrossRef

  27. 27
    Eleonora De Martin, Kryssia I Rodriguez-Castro, Alessandro Vitale, Giacomo Zanus, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra, Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long?, Future Virology, 2011, 6, 10, 1179

    CrossRef

  28. 28
    Eleonora Patsenker, Vreni Schneider, Monika Ledermann, Hans Saegesser, Christoph Dorn, Claus Hellerbrand, Felix Stickel, Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis, Journal of Hepatology, 2011, 55, 2, 388

    CrossRef

  29. 29
    P. Guillouche, C. Féray, Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation, Alimentary Pharmacology & Therapeutics, 2011, 33, 2
  30. 30
    Valeria Mas, Daniel Maluf, Kellie J. Archer, Amiee Potter, Jihee Suh, Ricardo Gehrau, Valeria Descalzi, Federico Villamil, Transcriptome at the time of hepatitis C virus recurrence may predict the severity of fibrosis progression after liver transplantation, Liver Transplantation, 2011, 17, 7
  31. 31
    Hengli Tang, Cyclophilin Inhibitors as a Novel HCV Therapy, Viruses, 2010, 2, 8, 1621

    CrossRef

  32. 32
    Marina Berenguer, Victoria Aguilera, Fernando San Juan, Salvador Benlloch, Angel Rubin, Rafael López-Andujar, Angel Moya, Eugenia Pareja, Eva Montalva, Maria Yago, Manuel de Juan, José Mir, Martín Prieto, Effect of Calcineurin Inhibitors in the Outcome of Liver Transplantation in Hepatitis C Virus-Positive Recipients, Transplantation, 2010, 90, 11, 1204

    CrossRef

  33. 33
    Nyingi M. Kemmer, Tiffany E. Kaiser, Guy W. Neff, Hepatitis C After Liver Transplantation: Treatment and Impact on Patient and Graft Survival, Current Hepatitis Reports, 2010, 9, 3, 161

    CrossRef

  34. 34
    N. Kemmer, G. Neff, Recipient-Based Approach to Tailoring Immunosuppression in Liver Transplantation, Transplantation Proceedings, 2010, 42, 5, 1731

    CrossRef

  35. 35
    L.J.W. van der Laan, M. Hudson, S. McPherson, P.E. Zondervan, R.C. Thomas, J. Kwekkeboom, A.S. Lindsay, A.D. Burt, G. Kazemier, H.W. Tilanus, M.F. Bassendine, H.J. Metselaar, Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus, Transplantation Proceedings, 2010, 42, 10, 4573

    CrossRef

  36. 36
    Roberto J. Firpi, Consuelo Soldevila-Pico, Giuseppe G. Morelli, Roniel Cabrera, Cynthia Levy, Virginia C. Clark, Amitabh Suman, Anthony Michaels, Chaoru Chen, David R. Nelson, The Use of Cyclosporine for Recurrent Hepatitis C After Liver Transplant: A Randomized Pilot Study, Digestive Diseases and Sciences, 2010, 55, 1, 196

    CrossRef

  37. 37
    Nicholas A. Shackel, Jade Jamias, Wassim Rahman, Emilia Prakoso, Simone I. Strasser, David J. Koorey, Michael D. Crawford, Deborah J. Verran, James Gallagher, Geoffrey W. McCaughan, Early high peak hepatitis C viral load levels independently predict hepatitis C–related liver failure post–liver transplantation, Liver Transplantation, 2009, 15, 7
  38. 38
    Zhe Liu, John M. Robida, Sreedhar Chinnaswamy, Guanghui Yi, Jason M. Robotham, Heather B. Nelson, Andre Irsigler, C. Cheng Kao, Hengli Tang, Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A, Hepatology, 2009, 50, 1
  39. 39
    Shigeru Marubashi, Keizo Dono, Hiroaki Nagano, Chiwan Kim, Tadafumi Asaoka, Naoki Hama, Shogo Kobayashi, Yutaka Takeda, Koji Umeshita, Morito Monden, Yuichiro Doki, Masaki Mori, Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence, Clinical Transplantation, 2009, 23, 6
  40. 40
    Amylynne J. Frankel, Abby S. Van Voorhees, Sylvia Hsu, Neil J. Korman, Mark G. Lebwohl, Bruce F. Bebo, Alice B. Gottlieb, Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation, Journal of the American Academy of Dermatology, 2009, 61, 6, 1044

    CrossRef

  41. 41
    Gabriella Lengyel, Zsolt Tulassay, Treatment of recurrent hepatitis C virus infection in patients after liver transplantation, Clinical and Experimental Medical Journal, 2009, 3, 2, 237

    CrossRef

  42. 42
    J. Levitsky, K. Doucette, Viral Hepatitis in Solid Organ Transplant Recipients, American Journal of Transplantation, 2009, 9,
  43. 43
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted, Clinics in Liver Disease, 2008, 12, 3, 637

    CrossRef

  44. 44
    Yoshihide Ueda, Yasutsugu Takada, Hironori Haga, Motoshige Nabeshima, Hiroyuki Marusawa, Takashi Ito, Hiroto Egawa, Koichi Tanaka, Shinji Uemoto, Tsutomu Chiba, Limited Benefit of Biochemical Response to Combination Therapy for Patients With Recurrent Hepatitis C After Living-Donor Liver Transplantation, Transplantation, 2008, 85, 6, 855

    CrossRef

  45. 45
    Bruno Roche, Didier Samuel, Liver transplantation in viral hepatitis: Prevention of recurrence, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1153

    CrossRef

  46. 46
    Adnan Said, Michael R Lucey, Liver transplantation: an update 2008, Current Opinion in Gastroenterology, 2008, 24, 3, 339

    CrossRef

  47. 47
    Ye H. Oo, Tracey Dudley, Peter Nightingale, Geoffrey Haydon, David Mutimer, Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation, Liver Transplantation, 2008, 14, 1
  48. You have free access to this content48
    Sumihito Tamura, Yasuhiko Sugawara, Treatment strategy for hepatitis C after liver transplantation, Journal of Hepato-Biliary-Pancreatic Surgery, 2008, 15, 2
  49. 49
    Michael Charlton, Approach to recurrent hepatitis C following liver transplantation, Current Gastroenterology Reports, 2007, 9, 1, 23

    CrossRef

  50. 50
    Jeong-Ik Park, Kun-Moo Choi, Sung-Gyu Lee, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Young-Hwa Chung, Yung-Sang Lee, Dong-Jin Suh, Clinical Outcome after Living Donor Liver Transplantation in Patients with Hepatitis C Virus-associated Cirrhosis, The Korean Journal of Hepatology, 2007, 13, 4, 543

    CrossRef

  51. 51
    A. Kornberg, B. Küpper, J. Wilberg, A. Tannapfel, K. Thrum, E. Bärthel, M. Hommann, U. Settmacher, Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients, Transplant Infectious Disease, 2007, 9, 4
  52. 52
    Marta Wawrzynowicz-Syczewska, Ewelina Herman, Krzysztof Jurczyk, Ewa Karpińska, Łukasz Laurans, Jerzy Lubikowski, Anna Boroń-Kaczmarska, Does cyclosporine inhibit in vivo hepatitis C virus replication? – a pilot study, Transplant International, 2007, 20, 9
  53. 53
    Marcus Mottershead, James Neuberger, Grafts and hepatitis C virus: Maximizing the benefit, Liver Transplantation, 2007, 13, 7
  54. 54
    Laura Cisneros, Maria-Carlota Londoño, Carmen Blasco, Ramón Bataller, Rosa Miquel, Miquel Bruguera, Pere Ginès, Antoni Rimola, Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C, Liver Transplantation, 2007, 13, 7
  55. 55
    J. Guitard, K. Sandres-Sauné, N. Kamar, D. Ribes, S. Faguer, L. Esposito, M. Lavit, F. Muscari, J.M. Péron, L. Lavayssière, D. Durand, L. Rostaing, Hepatitis C Virus Viral Load After Conversion From Tacrolimus to Cyclosporine in Liver Transplant Patients: A Pilot Study, Transplantation Proceedings, 2007, 39, 8, 2603

    CrossRef

  56. 56
    Olivier Boillot, Jérôme Dumortier, Immunosuppression in HCV-positive liver transplant recipients: Pandora's box?, Liver Transplantation, 2007, 13, 11
  57. 57
    Marina Berenguer, Ana Royuela, Javier Zamora, Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta-analysis, Liver Transplantation, 2007, 13, 1
  58. 58
    Adnan Said, Michael Einstein, Michael R Lucey, Liver transplantation: an update 2007, Current Opinion in Gastroenterology, 2007, 23, 3, 292

    CrossRef

  59. 59
    Mazen Alsatie, Naga Chalasani, Paul Y Kwo, Management of Hepatitis C Infection after Liver Transplantation, Drugs, 2007, 67, 6, 871

    CrossRef

  60. 60
    Marina Berenguer, Management of Hepatitis C Virus in the Transplant Patient, Clinics in Liver Disease, 2007, 11, 2, 355

    CrossRef

  61. 61
    Josep L Melero, Marina Berenguer, Optimum minimization strategies in hepatitis C virus infected liver transplant, Current Opinion in Organ Transplantation, 2007, 12, 6, 641

    CrossRef

  62. 62
    Speranta Iacob, Vito R. Cicinnati, Philip Hilgard, Razvan A. Iacob, Liana S. Gheorghe, Irinel Popescu, Andrea Frilling, Massimo Malago, Guido Gerken, Christoph E. Broelsch, Susanne Beckebaum, Predictors of Graft and Patient Survival in Hepatitis C Virus (HCV) Recipients: Model to Predict HCV Cirrhosis After Liver Transplantation, Transplantation, 2007, 84, 1, 56

    CrossRef

  63. 63
    Marco Antonio Olivera-Martínez, Juan F. Gallegos-Orozco, Recurrent Viral Liver Disease (Hepatitis B and C) after Liver Transplantation, Archives of Medical Research, 2007, 38, 6, 691

    CrossRef

  64. 64
    B. Roche, D. Samuel, Risk factors for hepatitis C recurrence after liver transplantation, Journal of Viral Hepatitis, 2007, 14,
  65. 65
    Robert S. Brown, Steroids in recurrent hepatitis C following liver transplantation: Pitfall or panacea?, Journal of Hepatology, 2007, 47, 6, 741

    CrossRef

  66. 66
    Gabriella Lengyel, Zsolt Tulassay, Treatment of recurrent hepatitis C virus infection after liver transplantation, Orvosi Hetilap, 2007, 148, 40, 1875

    CrossRef

  67. 67
    S.C. Rayhill, R. Barbeito, D. Katz, M. Voigt, D. Labrecque, P. Kirby, R. Miller, A. Stolpen, Y. Wu, W. Schmidt, A Cyclosporine-Based Immunosuppressive Regimen May Be Better Than Tacrolimus for Long-Term Liver Allograft Survival in Recipients Transplanted for Hepatitis C, Transplantation Proceedings, 2006, 38, 10, 3625

    CrossRef

  68. 68
    James R. Burton, Hugo R. Rosen, Acute rejection in HCV-infected liver transplant recipients: The great conundrum, Liver Transplantation, 2006, 12, S2
  69. 69
    A. Humar, M. Michaels, American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation, American Journal of Transplantation, 2006, 6, 2
  70. 70
    Yasuhiko Sugawara, Junichi Kaneko, Masatoshi Makuuchi, Cyclosporin A for Treatment of Hepatitis C Virus After Liver Transplantation, Transplantation, 2006, 82, 4, 579

    CrossRef

  71. 71
    V. C. McAlister, E. Haddad, E. Renouf, R. A. Malthaner, M. S. Kjaer, L. L. Gluud, Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation: A Meta-Analysis, American Journal of Transplantation, 2006, 6, 7
  72. 72
    Roberto J. Firpi, Haizhen Zhu, Giuseppe Morelli, Manal F. Abdelmalek, Consuelo Soldevila-Pico, Victor I. Machicao, Roniel Cabrera, Alan I. Reed, Chen Liu, David R. Nelson, Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation, Liver Transplantation, 2006, 12, 1
  73. 73
    Marina Berenguer, Victoria Aguilera, Martín Prieto, Fernando San Juan, José M. Rayón, Salvador Benlloch, Joaquín Berenguer, Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients, Liver Transplantation, 2006, 12, 5
  74. 74
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C Virus and Liver Transplantation, Clinics in Liver Disease, 2006, 10, 4, 919

    CrossRef

  75. 75
    Marina Berenguer, Hepatitis C virus in liver transplantation: impact and treatment of hepatitis C virus recurrence, Current Opinion in Organ Transplantation, 2006, 11, 6, 599

    CrossRef

  76. 76
    Martin F Sprinzl, Gerd Otto, Peter R Galle, Marcus Schuchmann, Hepatitis C virus re-infection: new perspectives, Clinical Transplantation, 2006, 20,
  77. 77
    E. Oton, R. Barcena, M. Castillo, M. Barreales, C. Blesa, J.M. Moreno-Planas, C. Barrios, A. Garrido, V. Cuervas, Hepatitis C Virus Recurrence After Liver Transplantation: Influence of Immunosuppressive Regimens on Viral Load and Liver Histology, Transplantation Proceedings, 2006, 38, 8, 2499

    CrossRef

  78. 78
    Sandeep Mukherjee, Elizabeth Lyden, Impact of pegylated interferon α-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series, Liver International, 2006, 26, 5
  79. You have free access to this content79
    Shigeru Marubashi, Keizo Dono, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita, Morito Monden, Liver transplantation for hepatitis C, Journal of Hepato-Biliary-Pancreatic Surgery, 2006, 13, 5
  80. 80
    Adnan Said, Michael R Lucey, Liver transplantation: an update, Current Opinion in Gastroenterology, 2006, 22, 3, 272

    CrossRef

  81. 81
    A. Kuo, N. A. Terrault, Management of Hepatitis C in Liver Transplant Recipients, American Journal of Transplantation, 2006, 6, 3
  82. 82
    Sakib K. Khalid, Jeffrey S. Crippin, Management of Hepatitis C in the Setting of Liver Transplantation, Clinics in Liver Disease, 2006, 10, 2, 321

    CrossRef

  83. 83
    Ashok Jain, Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection, Liver Transplantation, 2006, 12, 10
  84. 84
    Paul Martin, Recurrent hepatitis C post–liver transplant: The lessons learned, Liver Transplantation, 2006, 12, 5
  85. 85
    D.N. Samonakis, M. Mela, A. Quaglia, C.K. Triantos, U. Thalheimer, G. Leandro, A. Pesci, M.L. Raimondo, A.P. Dhillon, K. Rolles, B.R. Davidson, D.W. Patch, A.K. Burroughs, Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis, Transplant Infectious Disease, 2006, 8, 1
  86. 86
    Spencer Hoover, Adnan Said, Rob Striker, Tailoring immunosuppressants to hepatitis C virus–infected transplant patients, Transplantation Reviews, 2006, 20, 3, 157

    CrossRef

  87. 87
    Gary L. Davis, The challenge of progressive hepatitis C following liver transplantation, Liver Transplantation, 2006, 12, 1
  88. 88
    Marina Berenguer, Hepatitis C after liver transplantation: risk factors, outcomes, and treatment, Current Opinion in Organ Transplantation, 2005, 10, 2, 81

    CrossRef

  89. 89
    Hector Rodriguez-Luna, Hugo E. Vargas, Management of hepatitis C virus infection in the setting of liver transplantation, Liver Transplantation, 2005, 11, 5
  90. 90
    Roberto J. Firpi, David R. Nelson, Pathogenesis of recurrent hepatitis C after liver transplantation, Current Hepatitis Reports, 2005, 4, 4, 138

    CrossRef

  91. 91
    Y Sugawara, M Makuuchi, Present condition of liver transplantation and future problem. 5. Liver transplantation for liver cirrhosis centering on viral liver cirrhosis., Kanzo, 2005, 46, 6, 322

    CrossRef

  92. 92
    M.J. Bahr, J.G.P. Beckermann, K. Rifai, L. Gehrmann, J. Rosenau, J. Klempnauer, C.P. Strassburg, M.P. Manns, Retrospective Analysis of the Impact of Immunosuppression on the Course of Recurrent Hepatitis C After Liver Transplantation, Transplantation Proceedings, 2005, 37, 4, 1703

    CrossRef

  93. 93
    F. FABRIZI, J. BROMBERG, A. ELLI, V. DIXIT, P. MARTIN, Review article: hepatitis C virus and calcineurin inhibition after renal transplantation, Alimentary Pharmacology & Therapeutics, 2005, 22, 8
  94. 94
    Cyrille Féray, Steroid and azathoprine maintenance as the best regimen during recurrent hepatitis C?, Liver Transplantation, 2005, 11, 4
  95. 95
    Marina Berenguer, What determines the natural history of recurrent hepatitis C after liver transplantation?, Journal of Hepatology, 2005, 42, 4, 448

    CrossRef

  96. 96
    Elizabeth Haddad, Vivian McAlister, Elizabeth Renouf, Richard Malthaner, Mette S Kjaer, Lise Lotte Gluud, Cyclosporin versus tacrolimus for liver transplanted patients, The Cochrane Library,
  97. 97
    Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs, Liver Transplantation: Prevention and Treatment of Rejection,
  98. 98
    Manuel Rodríguez-Perálvarez, Marta Guerrero-Misas, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy, Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis, The Cochrane Library,